Page last updated: 2024-08-24

tenofovir and Melanoma

tenofovir has been researched along with Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eminler, AT; Hacibekiroglu, I; Koksal, AS; Parlak, E; Toka, B; Uslan, MI1
Martin, L1

Reviews

1 review(s) available for tenofovir and Melanoma

ArticleYear
[What's new in dermatological treatments?].
    Annales de dermatologie et de venereologie, 2010, Volume: 137 Suppl 4

    Topics: Adenine; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clinical Trials as Topic; Cyclosporine; Dermatofibrosarcoma; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Follow-Up Studies; Gels; HIV Infections; Humans; Imatinib Mesylate; Immunoglobulin G; Immunosuppressive Agents; Ipilimumab; Melanoma; Neoplasm Staging; Organophosphonates; Piperazines; Psoriasis; Pyrimidines; Receptors, Tumor Necrosis Factor; Skin Diseases; Skin Neoplasms; Survival Analysis; Tenofovir; Treatment Outcome; Ustekinumab

2010

Other Studies

1 other study(ies) available for tenofovir and Melanoma

ArticleYear
HBV-related acute hepatitis due to immune checkpoint inhibitors in a patient with malignant melanoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 12-01, Volume: 28, Issue:12

    Topics: Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antiviral Agents; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Ipilimumab; Male; Melanoma; Middle Aged; Nivolumab; Tenofovir

2017